Reagents kit for fetal SRY gene detection in maternal blood
- FOB Price:Get Latest Price >
- Min.Order:1 Vial(s)
- Favorite
Business Type:Manufacturer
Country/Region:Russia
Ddu Verified
HOT Rank
6/10
TestGene
TestGene develops and manufactures kits for molecular genetics intended for use in researching, practical medicine and in the fields of molecular biology. The focus-area: non-invasive genetic testing in obstetrics and oncology. TestGene has its own production laboratory with the necessary equipment for manufacturing and quality assurance of kits based on "real time PCR". The company team of researchers constantly improves the products according to the latest scientific achievements.
Business Type:Manufacturer
Country/Region:Russia
Ddu Verified
HOT Rank
6/10
Reagent kit for fetal gender identification by SRY gene detection in maternal blood since 10th week of pregnancy. The testing is performed on the base of polymerase chain reaction (PCR) with hybridization-fluorescence detection. DNA isolated from blood plasma are the material for PCR.
ANALYTICAL KIT CHARACTERISTICS
Diagnostic accuracy | 99,50% |
Diagnostic Sensitivity | 99,03% |
Diagnostic Specificity | 99,83% |
Analytical specificity | 100% |
Analytical sensitivity | 10 genome equivalents/µl (GE/µl) |
Application for reagents kit - laboratory diagnostics for DNA and sex determining region Y(SRY) detection in blood plasma of pregnant women from 10th embryologic week.
The kit is intended for use in medical and healthcare institutions including diagnostic and criminalistics laboratory as well as for scientific purpose.
Currently there are known about 300 genes localized in X chromosome which caused hereditary diseases. Those are genes of X-linked inchthyosis, fragile X syndrome, Coffin-Lowry syndrome, Payne syndrome, Opitz syndrome and many other diseases.
Moreover intrauterine fetus gender determination is possible by Ultrasonography although this method is applicable since 22nd week of pregnancy and it's considered that the accuracy doesn't prevail 70%.